Papaioannou, A.
McCloskey, E.
Bell, A.
Ngui, D.
Mehan, U.
Tan, M.
Goldin, L.
Langer, A.
Article History
Received: 15 July 2020
Accepted: 17 March 2021
First Online: 24 April 2021
Declarations
:
: Institutional approval was not sought for this study as it represents a quality improvement initiative. Informed consent was obtained from all individual participants included in the study.
: Dr. Alexandra Papaionnou has been on the Amgen Advisory Board and has received research support and honoraria from Amgen.Dr. Langer has received on behalf of the Canadian Heart Research Centre research grant support from Actelion, Amgen, Bayer, BMS, Merck, Novo Nordisk, Pfizer, Servier and Sanofi.